CoChat

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Open access
Liu, Anthony P.Y., Smith, Kyle S., Kumar, Rahul, Paul, Leena, Bihannic, Laure, Lin, Tong, Maass, Kendra K., Pajtler, Kristian W., Chintagumpala, Murali, Su, Jack M., Bouffet, Eric, Fisher, Michael J., Gururangan, Sridharan, Cohn, Richard, Hassall, Tim, Hansford, Jordan R., Klimo, Paul, Boop, Frederick A., Stewart, Clinton F., Harreld, Julie H., Merchant, Thomas E., Tatevossian, Ruth G., Neale, Geoffrey, Lear, Matthew, Klco, Jeffery M., Orr, Brent A., Ellison, David W., Gilbertson, Richard J., Onar-Thomas, Arzu, Gajjar, Amar, Robinson, Giles W., Northcott, Paul A. · 2021 · Cancer Cell
Cited by 177

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary Nearly one-third of children with medulloblastoma, a malignant embryonal tumor of the cerebellum, succumb to their disease. Conventional response monitoring by imaging and cerebrospinal fluid (CSF) cytology remains challenging and a marker for measurable residual disease (MRD) is lacking. Here, we show the clinical utility of CSF-derived cell-free DNA (cfDNA) as a biomarker of MRD in serial samples collected from children with medulloblastoma (123 patients, 476 samples) enrolled on a prospective trial. Using low-coverage whole-genome sequencing, tumor-associated copy-number variations (CNVs) in CSF-derived cfDNA are investigated as an MRD surrogate. MRD is detected at baseline in 85% and 54% of patients with metastatic and localized disease, respectively. The number of MRD-positive patients decline with therapy, yet those with persistent MRD have significantly higher risk of progression. Importantly, MRD detection precedes radiographic progression in half who relapse. Our findings advocate for the prospective assessment of CSF-derived liquid biopsies in future trials for medulloblastoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.09.012

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Liu, A. P. Y., Smith, K. S., Kumar, R., Paul, L., Bihannic, L., Lin, T., Maass, K. K., Pajtler, K. W., Chintagumpala, M., Su, J. M., Bouffet, E., Fisher, M. J., Gururangan, S., Cohn, R., Hassall, T., Hansford, J. R., Klimo, P., Boop, F. A., Stewart, C. F., Harreld, J. H., Merchant, T. E., Tatevossian, R. G., Neale, G., Lear, M., Klco, J. M., Orr, B. A., Ellison, D. W., Gilbertson, R. J., Onar-Thomas, A., Gajjar, A., Robinson, G. W., & Northcott, P. A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2021-11
Volume
39
Issue
11
Pages
1519-1530.e4
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3206226697
Cited by
177
References
6
FWCI
12.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.